Загрузка...
Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model
AIM: To improve anti-inflammatory activity while reducing drug doses, we developed a nanoformulation carrying dexamethasone and butyrate. METHODS: Dexamethasone cholesteryl butyrate-solid lipid nanoparticles (DxCb-SLN) were obtained with the warm microemulsion method. The anti-inflammatory activity...
Сохранить в:
| Опубликовано в: : | World J Gastroenterol |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Baishideng Publishing Group Inc
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483494/ https://ncbi.nlm.nih.gov/pubmed/28694660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i23.4200 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|